Phathom Pharmaceuticals (PHAT)

Phathom Pharmaceuticals (PHAT) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• PHAT last traded at $5.92, 3.05% on the day.
• Phathom Pharmaceuticals: market cap $466.61M, P/E -5.7, revenue $274.88M over the last four quarters.
• Over the past year PHAT returned -55.56%; year to date -64.35%.

Updated 2026-11-03 04:17 UTC